Karl Henrik Johannes Ehinger

Title: Innovations of Karl Henrik Johannes Ehinger

Introduction

Karl Henrik Johannes Ehinger is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of biochemistry, particularly in the development of novel compounds aimed at enhancing mitochondrial function. With a total of three patents to his name, Ehinger's work focuses on improving ATP production in cells.

Latest Patents

Ehinger's latest patents include innovative cell-permeable succinate compounds. These inventions provide novel cell-permeable succinates and precursors aimed at increasing ATP production in mitochondria. The primary source of ATP in eukaryotic cells is mitochondrial oxidative phosphorylation, which relies on high-energy electrons supplied by the Kreb's cycle. However, not all intermediates of the Kreb's cycle can easily cross cellular membranes, with succinate being one such example. Ehinger's cell-permeable succinates are designed to facilitate this passage, thereby enhancing mitochondrial ATP output.

Career Highlights

Throughout his career, Ehinger has worked with various companies, including Abliva AB and Neurovive Pharmaceutical AB. His expertise in biochemistry and innovative approach to problem-solving have made him a valuable asset in the pharmaceutical industry.

Collaborations

Ehinger has collaborated with notable colleagues such as Magnus Joakim Hansson and Steven James Moss. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Karl Henrik Johannes Ehinger is a distinguished inventor whose work in cell-permeable succinate compounds has the potential to significantly impact mitochondrial ATP production. His contributions to biochemistry and collaborations with industry professionals highlight his importance in the field.